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Introduction: Using electrospun nanofiber scaffolds have emerged as a technique for tissue 
engineering (TE) applications.  In 2011, Sullivan et al. reported on the process to effectively 
electrospin and crosslink nanofibers from poly(ethylene oxide) (PEO) and β-lactoglobulin (BLG) 
aqueous solutions. PEO and BLG are both biodegradable and biocompatible materials.  
Crosslinking PEO/BLG nanofibers is necessary to improve their aqueous stability for TE 
applications.  However, the heat treatment process suggested by Sullivan et al. is time intensive.  
The purpose of this study was to a) investigate an alternative crosslinking method for electrospun 
nanofibers made from an aqueous protein solution b) assess the resulting nanofibers for their 
potential use as scaffolds for TE applications, and c) evaluate the effect of biologically treated 
nanofiber scaffolds on stem cell proliferation.  Chemical crosslinking techniques using Sodium 
Trimetaphosphate (STMP) combined with sodium hydroxide (NaOH) were evaluated.  STMP 
has been shown to effectively crosslink polysaccharide nanofibers in situ during electrospinning.  
Methods: STMP, at various concentrations, was added to PEO/BLG electrospinning solutions.  
The effects of STMP were characterized by measuring the solution’s viscosity, pH and 
conductivity.  Confocal laser scanning microscopy (CLSM) images were acquired to 
qualitatively assess electrospun nanofiber morphology and scaffold topography.  Human 
mesenchymal stem cells (hMSC) were grown on PEO/BLG scaffolds under control conditions 
and when treated with the protein Thymosin-β4 (Tβ4).  HMSC proliferation was assessed to 
evaluate the effects of PEO/BLG nanofiber scaffolds and different Tβ4 treatments at day 2, 4 and 
8.  Results: Using STMP to chemically crosslink PEO/BLG electrospun scaffolds affected 
solution properties, nanofiber morphology and scaffold topography.  PEO/BLG/STMP 
nanofibers were highly beaded and wavy with little structure relative to PEO/BLG nanofibers.  
Fibers were not stable in an aqueous solution.  Using Tβ4 to treat the PEO/BLG nanofiber 
scaffolds and/or cell culture media improved hMSC proliferation with increased time in culture.  
HMSCs remained viable throughout the growth period for all treatments.  However, hMSCs did 
not integrate into PEO/BLG nanofiber scaffolds, but attached to the scaffold surface.  
Conclusion: Using STMP, at the tested concentrations, as an alternative crosslinker for 
PEO/BLG nanofibers was ineffective and did not result in usable electrospun scaffolds.  
Chemically crosslinking PEO/BLG nanofibers requires further research in polymer chemistry to 
identify an alternative in situ crosslinking mechanism.  Treating the scaffolds and/or media with 
Tβ4 did result in improved hMSC proliferation.  However, while hMSC cultures remained viable 
and proliferation increased with Tβ4 treatments, further research is necessary to develop 
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CHAPTER 1 – Background, Motivation and Goals 
1.1. Background 
1.1.1. Tissue Engineering 
Tissue engineering (TE), a subspecialty of regenerative medicine, is the interdisciplinary 
field involving knowledge from medicine, biology, engineering and materials science that 
includes the in vitro and in vivo development of tissue (Agawal, Wendorff, & Greiner, 2008; 
Lodono & Badylak, 2015).  Due to trauma, organ/tissue failure and congenital defects, and 
conventional methods to treat and repair tissue defects, TE efforts aim to provide an innovative 
and promising alternative to treat these deleterious conditions by generating complex tissue and 
organs in an in vitro approach.  This approach decreases the need for organ donors. Its novelty 
arises from utilizing the smallest components of tissue to engineer complex tissue, stem cells and 
the extracellular matrix (ECM).  An approach to develop tissue in vitro is to use scaffolds to 
provide a temporary support where stem cells can be seeded, allowing them to grow and 
proliferate. Scaffolds are designed to biomimic the ECM by using biocompatible and 
biodegradable materials.  In the process the scaffolds biodegrade and are replaced by ECM 
produced by stem cells, subsequently forming differentiated and specified tissue.  The following 
sections provide an overview of the natural ECM, and relevance of biodegradable scaffolds to 
TE.  
1.1.2. The Extracellular Matrix 
Natural extracellular matrix is a 3-dimensional mesh-network that surrounds cells, providing 
anchorage and separation between tissues (Agawal, Wendorff, & Greiner, 2008).  ECM is 
composed of various structural and functional proteins, such as collagen, elastin, proteoglycan, 
fibronectin and laminin, secreted and maintained by resident cells (Stevens & George, 2005). 
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ECM diversification results from different combinations and interactions of these proteins.  Due 
to evolutionary changes in vertebrates, tissues vary in anatomical complexity as does their native 
ECM architecture.  The ECM has been well characterized for its role in providing structural 
support for tissues.  A 2009 review (Agarwal, Wendorff, & Greiner, 2009) presented research 
evidence supporting the biological importance of the ECM’s protein and mechanical 
characteristics.  Researchers now acknowledge ECM’s paramount role in multiple cellular 
functions that provide chemical and mechanical cues to maintain cellular homeostasis, optimize 
tissue and organ function, and modify the microenvironment to mediate wound healing and 
tissue repair (Hynes, 2009; Lodono & Badylak, 2015).   
Advancements in health care, medicine, organ-transport modalities and surgery has led to 
improvements for organ transplantation outcomes.  According to the Organ Procurement and 
Transplant Network, organ transplants have increased 2.2 fold from 1988 to 2012.  However, 
issues stem from the inequality in organ donor donations and number of people on the organ 
donor waiting list.  From 1988 to 2012, organ donors increased by 2.3-fold while the number of 
patients on the waiting list increased by 7.8 -fold (Hunsberger, Neubert, Wertheim, Allickson, & 
Atala, 2016).  The long term goals of TE are to develop techniques and modalities to diminish 
the use of donor tissue.  Thus, understanding the ECM’s biological and structural properties at 
the micro-level is essential and well established.  Research has shown engineered biodegradable 
scaffolds to have a promising future for developing tissue in vitro as an alternative for donor 
organ/tissue outsourcing (Agarwal, Wendorff, & Greiner, 2009; Chiu & Radisic, 2011; Lodono 





1.1.3. Scaffolds in Tissue Engineering 
Biological scaffold architecture plays a critical role in TE, as it must mimic the native ECM’s 
physical dimensions and physiological conditions.  Biological scaffolds with nanofiber 
architecture are ideal for TE applications as they provide larger surface area for absorbing 
proteins and present more binding sites to cell menbrane receptors compared to micropore and 
microfiber scaffolds (Agarwal, Wendorff, & Greiner, 2009).  Biological scaffolds also provide 
high porosity for diffusing nutrients, growth factors and other biological elements.  These 
features allow for enhanced ECM biomicry when using nanofiber scaffolds compared to their 
counterparts. An additional feature intrinsic to some biological scaffold modalities is that 
porosity can be controlled and modified by making simple modification to the scaffold 
generating process.  Controlling scaffold porosity allows for the optimization  of diffusion and 
cell-to-cell communication for specific cell types.  
Material selection is another fundamental factor when creating biological scaffolds for TE. 
Materials must be biocompatible to prevent an immunoresponse, nontoxic to enhance cell 
viability, and biodegradible to allow cells to form and replace the scaffolds with native ECM. 
Furthermore, biodegradation is an important aspect to cell viability, as degradation byproducts 
must also be nontoxic. As cells grow and proliferate, scaffold materials must biodegrade at a rate 
similar to that of native ECM formation to further promote cell viability.  TE applications using 
nanofiber scaffolds represent a nontrivial process requiring a fine balance between scaffold 
biodegradation and ECM formation to promote tissue formation, i.e., as a scaffold biodegrades, it 
is infiltrated by host cells and eventually replaced with native ECM leading to functional and 





While there are multiple methods to create nanofiber scaffolds, such as template synthesis, 
phase separation and self-assembly, and electrospinning (Kriegel, Arrechi, Kit, McClements, & 
Weiss, 2008), electrospinning is one of the most efficient, simple and versatile methods due to its 
relatively simple approach and cost-effective setup.  Electrospun nanofibers are produced by 
applying a strong electric field between two electrodes in which a polymer solution is 
continuously pumped through a capillary or a needle (or spinneret) (Figure 1.1B).  At the tip of 
the spinneret, the electrospinning solution forms a jet that travels to a collecting surface (an 
opposite or grounded electrode) due to electrostatic repulsive forces.  The spinning jet is exposed 
to air and dries as it travels to the collecting surface.  The nanofibers randomly accumulate on the 
collecting surface giving the scaffold its porous architecture.  Figure 1.1A provides an 
illustration of a basic electrospinning setup.  Nanofibers are characterized by their average fiber 
diameter. Factors such as solution properties (viscosity and conductivity), distance between 
electrodes (tip-to-collector distance), flow rate, electrospinning voltage, relative humidity (partial 
pressure for solutions made with organic solvents) and temperature play a critical role in 
producing defect-free nanofibers.  
Due to its simplicity, versatility and cost effective set-up, electrospinning in TE applications 
has gained popularity in the recent decades.  The number of scientific publications describing the 
use of this technique has increased yearly.  Electrospinning for TE applications currently 
emphasizes two applications: i) formation of nonwoven mats of different biomaterials to mimic 
physical dimensions of native EMCs, that is, geometry and morphology with nanodimensions, 
and ii) modification of the electrospinning process or electrospun fibers for achieving enhanced 




Figure 1.1: Electrospinning equipment at East Carolina University. (A) An electric field is 
established in the space between the spinneret (positive electrode) and collector plate (grounded) 
during electrospinning. (B) The circuit is completed when connecting the electrodes to a power 
supply and applying a voltage. The charges in the solution are repelled from the positive 
electrode towards the grounded collector plate initiating nanofiber formation. 
A 
B 
Syringe & Pump 
(+) Electrode 







1.1.5. Materials in Electrospinning 
Choosing scaffold materials for TE, depends on the nature of the tissue to be regenerated and 
the regeneration time (Agarwal, Wendorff, & Greiner, 2009).  Thus, a variety of biodegradable 
synthetic and natural polymers have been studied, as well as combinations of both. Synthetic 
polymers have been extensively studied and one particular review article reported nearly 50 
synthetic polymers have been successfully electrospun with numerous applications (Huang, 
Zhang, Kotaki, & Ramakrishna, 2003).  Electrospun synthetic nanofiber research has been 
applied to military protective clothing for minimizing air impedance and anti-biochemical gases,  
thermal and biochemical nanosensors, cosmetic skin masks for skin cleansing and skin healing, 
life sciences for drug delivery carriers and wound dressings, filter media for gas filtration and 
molecule filtration, TE scaffolding for porous membrane for skin and 3D scaffolds for bone and 
cartilage regeneration (Huang, Zhang, Kotaki, & Ramakrishna, 2003). Synthetic polymers such 
as poly(caprolactone) (PCL), poly(lactide) (PLA), poly(ethylene oxide) (PEO), polyglycolic acid 
(PGA), and others, have been categorized as biodegradable and identified for TE applications 
(Huang, Zhang, Kotaki, & Ramakrishna, 2003; Subbiah, Bhat, Tock, Parameswaran, & 
Ramkumar, 2005).  Research suggests that electrospinning biodegradable and biocompatible 
synthetic polymers is feasible and the ease of availability, understanding of their chemical and 
mechanical properties, and ease of spinnability makes synthetic polymers suitable candidates for 
electrospinning. 
Electrospinning methods have been used to generate scaffolds for TE using different natural 
biopolymers including proteins and polysaccharides (Agawal, Wendorff, & Greiner, 2008). 
Using natural biopolymers can provide instructive cues required for cell attachment and 
proliferation, thus having a physiologic advantage over biocompatible and biodegradable 
7 
 
synthetic polymers (Agarwal, Wendorff, & Greiner, 2009).  However, natural biopolymers 
display poor electrospinning processability due to lack of entanglement and high surface tension. 
They often require modifications for better electrospinnability (Jeong, et al., 2011).  In addition, 
natural polymers must be derived and/or isolated from their original source, thus making them 
scarce (Li, He, Zheng, & Han, 2006).  Therefore, a combination of both synthetic and natural 
polymers have been investigated. Mixtures of both polymer groups result in composite 
nanofibers that are more suitable for TE scaffolds.  These mixtures combine the advantage of 
property modification of synthetic polymers and the biofunctionality of natural polymers 
(Agawal, Wendorff, & Greiner, 2008). 
1.2. Motivation and Goals 
The purpose of this study was to a) investigate an alternative crosslinking method for 
electrospun nanofibers made from an aqueous protein solution b) assess the resulting nanofibers 
for their potential use as scaffolds for TE applications, and c) evaluate the effect of biologically 
treated nanofiber scaffolds on stem cell proliferation.  Electrospinning nanofibers from natural 
materials (biopolymers) can be difficult, and successful defect-free nanofiber generation is 
limited to certain biopolymers, which may require chemical modification (Ji, et al., 2006). 
Research has shown combinations of natural polymers and synthetic polymers to improve 
electrospinning outcomes and nanofiber generation without the need for chemical modification. 
This prospect suggests a promising future for natural/synthetic electrospun nanofibers. 
Whey proteins are naturally occurring and edible, regarded as safe by the US FDA, and used 
as food and material modifiers, and nutritional supplements (Sullivan S. T., 2011).  In addition to 
their nutritional value as a protein source, studies have investigated the biological activity of 
whey proteins.  Whey proteins possess prophylactic properties and may offer specific health 
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benefits such as antibacterial, antiviral, anticarcinogenic effects, and synthesis of antioxidant and 
other bioactive peptides (Chatterton, Smithers, Roupas, & Brodkorb, 2006; Madureira, Pereira, 
Gomes, Pintado, & Xavier Malcata, 2007; Hernández-ledesma, Recio, & Amigo, 2008).  As a 
result, whey proteins have gained research attention outside the food industry and nutritional 
field for pharmaceutical and biomedical applications.  
β-lactoglobulin (BLG) is one of the principle components of whey proteins found in the milk 
of ruminant species and some non-ruminant species such as pigs, horses, dolphins and cats 
(Hernández-ledesma, Recio, & Amigo, 2008).  A study investigated solution electrospinning of 
whey protein isolate (WPI) and BLG using Poly(ethylene oxide) (PEO), a water-soluble 
synthetic polymer, as a carrier polymer to enhance spinnability. Different PEO\WPI and 
PEO/BLG blends were electrospun and evaluated.  The study reported fibers with the highest 
WPI concentration were less uniform in diameter, had a higher mean diameter and wider size 
distribution, and minor fiber breakage present upon characterization (Sullivan, Tang, Kennedy, 
& Tawlar, 2014).  Nanofibers with the highest BLG concentration did not have these 
characteristics when compared to their WPI counterparts. In addition, PEO/BLG blends 
produced fibers with a smaller mean diameter and standard deviation compared to PEO/WPI 
blends of the same proportion.  The researchers also investigated heat treatment for improving 
nanofiber insolubility. PEO and PEO/BLG nanofibers were heat treated for 24 to 44 hours at  
100 
o
C.  Nanofiber morphology was retained for several days after being immersed in water. 
This research suggested covalent crosslinking occurred during heat treatment.  This result was 
expected since the treatment temperature was above the gelation temperature of whey protein 




This project using BLG to create electrospun nanofibers originated from the previous work 
described by Sullivan et at.  Published research showed PEO/BLG blends produced less variant 
nanofibers than PEO/WPI blends, and their water insolubility and stability to be improved by 
heat treatment. Other studies have identified whey proteins to have prophylactic effects that may 
offer specific health benefits, including antibacterial, antiviral and anticarcinogenic effects 
(Hernández-ledesma, Recio, & Amigo, 2008).  These three attributes formed the basis of this 
study to determine if PEO/BLG electrospun nanofibers could serve as a TE scaffold and enhance 
stem cell viability. 
The first goal of this study was to investigate an alternative to crosslinking via heat treatment. 
Based on the methods proposed by Sullivan et al., the time required to produce and crosslink 
nanofiber scaffolds was determined to be 7 days: 1 day for solution preparation, 2 days for 
electrospinning and 4 days for crosslinking (unpublished data from Richard Steiner 2014, 
presented during ECU’s Research and Creative Activity Week).  Heat treatment accounts for 
over 50% of the time required to produce nanofiber scaffold. To expedite scaffold generation, in 
situ crosslinking by sodium trimetaphosphate (STMP) was investigated.  STMP has been shown 
to effectively crosslink hyaluronan (Dulong, et al., 2004), xanthan (Bejenariu, Popa, Dulong, 
Picton, & Le Cerf, 2009) and pullulan hydrogels (Lack, et al., 2004) and pullulan/dextran 
nanofibers (Shi, Le Visage, & Chew, 2011; Jiang, et al., 2015). Studies using PEO/BLG 
nanofibers crosslinked with STMP, or other whey proteins, have not been reported.  The goal 
was to establish a critical STMP concentration and electrospinning parameters to produce defect-
free and crosslinked PEO/BLG nanofibers. STMP concentrations reported by Shi et al. ranged 
from 4-16 w/v %. STMP requires sodium hydroxide (NaOH) to provide alkaline conditions to 
activate crosslinking.  Two studies using pullulan/dextran nanofibers reported successful 
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crosslinking with 10 w/v % NaOH aqueous solution at a volume ratio of 1:10 (NaOH:polymer 
solution) (Shi, Le Visage, & Chew, 2011; Jiang, et al., 2015).  The addition of STMP at various 
concentrations manifests changes in solution viscosity. Solution viscosity plays a major role in 
electrospinning and has a substantial influence on other electrospinning parameters such as 
electric field magnitude, solution flow rate and tip-to-collector distance.  
The second goal of this study was to determine the effect of PEO/BLG nanofiber scaffolds 
on stem cell proliferation.  This included treating PEO/BLG nanofiber scaffolds with thymosin-
β4 (Tβ4). Tβ4 has previously been shown to promote stem cell proliferation and wound healing  
(Byrum, 2008).  
Adult tissues contain stem cell populations capable of regenerating tissue after trauma, 
disease or aging by differentiating into tissue specific cells.  Human mesenchymal stem cells 
(hMSCs) are multipotent cells that can proliferate in their undifferentiated state, and have the 
potential to differentiate into multiple cells lines (Pittenger, et al., 1999).  HMSCs are autologous 
cells derived from a donor’s or patient’s bone-marrow. Using autologous hMSCs for therapy 
diminishes the likelihood of eliciting an immunoresponse and/or rejection if used in TE 
applications.  These attributes make hMSCs, an attractive candidate for TE research with a 
promising future for developing clinical applications. 
Tβ4 is a polypeptide that participates in various cellular functions, such as migration, 
adhesion, differentiation, angiogenesis and wound healing (Crockford, Turjman, Allan , & 
Angel, 2010; Kim & Jung, 2015).  Considering Tβ4’s physiological properties and its role in 
cellular functions, studies promoting cell migration, angiogenesis and cardiac wound healing 
have investigated and demonstrated the efficacy of using Tβ4 as a functionalizing agent for 
chitosan-collagen hydrogel constructs and poly(ε-caprolactone) electrospun nanofiber scaffolds, 
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respectively (Chiu & Radisic, 2011; Chiu & Radisic, 2011).  To the best of our knowledge, 




CHAPTER 2 - Materials and Methods 
Materials 
2.1. Poly(ethylene oxide) 
Poly(ethylene oxide) (PEO) is a semicrystalline and biodegradable thermoplastic polymer. 
PEO is soluble in water and polar organic solvents, and thus, it is a polymer whose solution 
properties have been extensively studied (Ho, Hammouda, Kline, & Chen, 2006).  Due to its 
biocompatibility and low toxicity, PEO has gained attention for its use in biomedical and food 
applications (Colín-Orozco, Zapata-Torres, Rodríguez-Gattorno, & Pedroza-Islas, 2015).  
A PEO/water system has been shown to be a simple model for studying fundamental 
biomolecular interactions in which hydrogen-bonding and hydrophobic interactions play 
important roles, such as in protein folding and stabilizations (Ho, Hammouda, Kline, & Chen, 
2006).  Due to the similarity of the basic interactions involved in PEO/water and protein/water 
systems (hydrogen bonding and electrostatic interactions), PEO has been studied and used as a 
visco-modifier to enhance the electrospinnability of biopolymers. Solutions combining PEO with 
egg albumin (Wongsausulak, Kit, McClements, Yoovidhya, & Weiss, 2007), sodium alginate 
(Lu, Zhu, Guo, Hu, & Yu, 2006), soy protein isolate (Ramji & Shah, 2014), keratin (Aluigi, et 
al., 2008), chitosan/alginate (Jeong, et al., 2011) and WPI have been reported to produce 
electrospun nanofibers (Sullivan, Tang, Kennedy, & Tawlar, 2014).  
2.2. β-lactoglobulin 
β-lactoglobulin (BLG) is the major whey protein in milk, generally accounting for 
approximately 50% of the total protein in ruminant milk, and 10% of the total protein in bovine 
milk (Chatterton, Smithers, Roupas, & Brodkorb, 2006).  BLG is a small protein, soluble in 
dilute salt solutions, with 162 amino acid residues that fold up into 8-stranded, perpendicular β-
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barrel with a 3-turn α-helix on the outer surface and a ninth β-strand flanking the first strand 
(Kontopidis, Holt, & Sawyer, 2004).  Its primary sequence reveals two intrachain disulphide 
bridges (Cys66-Cys160 and Cys109-Cys119) and a free thiol group at Cys121 (Hernández-
ledesma, Recio, & Amigo, 2008; Creamer, Parry, & Malcolm, 1983).  The reactive thiol has a 
pH dependent activity. At pH > 6.7, the thiol is susceptible to chemical modification favoring the 
binding of positively charged reagents to the sulfur atom in Cys121 (Qin, et al., 1998), and thus a 
potential site for chemical crosslinking. 
2.3. Sodium Trimetaphosphate 
Sodium trimetaphosphate (STMP), (NaPO3)3, is a water soluble, crystalline cyclic 
polyphosphate inorganic salt with a molecular weight of 305.92 Da (Lanigan, 2001).  STMP is 
accepted by the Food and Drug administration and has been used to prepare food-grade 
phosphorylated starches (Food additives permitted in food for human consumption, 1995). 
STMP is safe and non-toxic, and has been used to crosslink polysaccharides under alkaline 
conditions (Dulong, et al., 2004).  STMP is used in cosmetics as a buffering agent, chelating 
agent and pH modifier (Lanigan, 2001).  
2.4. Thymosin-β4 
Thymosin-β4 (Tβ4) is a major G-actin sequestering protein in all eukaryotic cells and is a 
potent regulator of actin polymerization in mammals (Kim & Jung, 2015), essential for 
extracellular matrix assembly and reorganization.  This 43-amino acid chain that was first 
isolated from bovine thymus tissue and has been found ubiquitously in the body (Crockford, 
Turjman, Allan , & Angel, 2010).  Research has shown that Tβ4 plays a major role in different 
cellular functions including wound healing, angiogenesis, migration, proliferation and 
suppressing inflammatory response (Ti, et al., 2015).  
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While studies have demonstrated these cellular functions in in vivo models to treat cutaneous 
wounds and various types of ischemia, these models often use direct injection to deliver 
treatment which often result in a decrease in efficacy due to inability to control Tβ4 release and 
concentrations over time.  Hence, new models are required to further investigate the effects of 
prolonged Tβ4 treatment.  Current research efforts, specifically in tissue engineering (TE), have 
approached the issue of in vitro applications by functionalizing TE scaffolds.  These new in vitro 
models allow for a vehicle where Tβ4 concentration and release are controlled over extended 
periods of time in laboratory settings.  Further understanding the prolonged effects of Tβ4 
exposure to cell cultures is necessary for understanding the full effects Tβ4 in physiological 
systems.  This may lead to developing Tβ4 treatments in clinical settings.  
Methods 
2.5. Solution Preparation 
BIOPURE β-lactoglobulin (BLG) was obtained from Davisco Foods Inc. (Eden Prairie, 
MN).  Poly(ethylene oxide) (PEO, MW 600 kDa) and sodium hydroxide (NaOH, MW 40 Da) 
were obtained from Sigma-Aldrich
 
Corporation (St. Louis, MO).  Sodium trimetaphosphate 
(STMP, MW 305.89 Da) was obtained from Alfa Aesar
®
 (Ward Hill, MA).  All materials were 
used as received. To prepare control solutions, PEO and BLG powder were added in deionized 
sterile water and mixed for one hour at room temperature (27º C) to make 8 w/v % PEO and 12 
w/v % BLG solutions (See Appendix A).  The solutions were combined at a 1:1 volume ratio and 
stirred overnight.  
Solutions with STMP were prepared in the same manner as the standard solution; however, 
10 w/v % aqueous NaOH was added to 12 w/v% BLG solution at a 1:20 volume ratio prior to 
combining PEO and BLG solutions.  STMP was added to the PEO/BLG solution at 2, 4, 6 and 8 
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w/v % concentrations.  Rhodamine-B and additional deionized sterile water was added to the 
solution at a concentration of 0.0005 v/v % and at a volume ratio of 1:10 (water/solution) and 
stirred for one hour before electrospinning.   
2.6. Solution Electrospinning 
The electrospinning equipment, previously described (Saquing, Manasco, & Khan, 2009), 
included a Harvard Apparatus precision syringe pump (Holliston, MA) with a flow rate between 
0.1-2.0 mL/h, and a Gamma High Voltage Research High-Voltage Power Supply (Model D-
ES30 PN/M692) with a positive polarity between 0 and 30 kV. A 10 ml syringe with a stainless 
steel capillary metal-hub needle attached was filled with the electrospinning solution. When 
placed on the syringe pump the needle tip-to-collector distance was 15 cm. Solutions were 
electrospun for approximately 48 hours. 
2.7. Characterizations of Electrospinning Solutions 
Viscosity measurements were collected for PEO/BLG plus NaOH and PEO/BLG/STMP 
solutions for each STMP concentration.  PEO/BLG solutions served as the control.  Rheometric 
measurements were performed using an AR 2000 EX Rheometer from TA Instruments (New 
Castle, DE) with a 40 mm 2° steel cone geometry.  A ramp shear stress in the range of 0.0 to 
20.0 Pa was applied at a constant temperature of 25 °C, controlled by a Peltier plate device. 
Solution conductivity and pH were recorded with an YSI 3100 conductivity instrument 
(Yellow Springs, OH) and an Accumet® AB150 pH/mV meter (Rocklin, CA) prior to 
electrospinning.   
2.8. PEO/BLG/STMP Scaffold Characterization   
To evaluate nanofiber morphology and scaffold topography, fluorescent confocal laser 
scanning microscopy (CLSM) was used to acquire 1.0 μm thick images of the electrospun 
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scaffolds.  The fluorescent dye Rhodamine-B (RhB) was obtained from Sigma-Aldrich
 
Corporation and added to the solutions, before electrospinning, to facilitate CLSM imaging.  
CLSM images were acquired with a Zeiss LSM 700 confocal microscope (Thornwood, NY) 
equipped with a 20x/0.75NA air objective.  Images were acquired with a 488 nm photodiode 
laser with a 555 nm emission filter.   
To evaluate chemical crosslinking and water insolubility, dried scaffolds were immersed in 
Phosphate Buffered Saline (PBS) for 24 hours and imaged with CLSM.  
2.9. PEO/BLG Scaffold Preparation for hMSC Cultures and Thymosin-β4 Treatment 
After scaffolds were electrospun, circular sections were cut to a diameter of 14mm, placed on 
aluminum foil and crosslinked at 100°C for approximately 96 hours (See Appendix A).  The 
scaffolds were sterilized by UV-irradiation for at least 12 hours per side.  Scaffolds were placed 
in multi-well cell culture plates, hydrated in PBS and incubated at 37°C in a humidified 5% CO2 
atmosphere for 24 hours.  To coat scaffolds with Tβ4 (BACHEM, CA), scaffolds were hydrated 
in PBS containing 10 μg/mL Tβ4 for 24 hours. After hydration and prior to cell seeding, the 
media was carefully removed and Tβ4 coated scaffolds were washed once with PBS to remove 
any excess unbound Tβ4 (See Appendix A). 
2.10. Cell Seeding and Cultures 
HMSC were acquired from The Texas A&M Science Center (College Station, TX). HMSCs 
were thawed, pelletized and counted to determine their live-to-dead ratio.  Cultures were 
prepared in two types of media: (1) Dulbecco’s Modified Eagle Medium, (DMEM, Gibco) and 
(2) DMEM containing 1μg/mL T4 (Tβ4-DMEM). HMSCs were seeded in triplicate at a 
concentration of approximately 500,000 cells/mL/well over four experimental groups shown in 
Figure 2.1: (1) scaffolds in DMEM (control), (2) T4 coated scaffolds in DMEM, (3) scaffolds 
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in T4-DMEM, and (4) T4 coated scaffolds in T4-DMEM. HMSCs were allowed to grow for 
eight days; culture media was exchanged every 4 days. 
 
2.11. HMSC Proliferation 
Cell proliferation was evaluated at day 2, 4 and 8 days after hMSC seeding using 
colorimetric assay Promega CellTiller 96
®
 AQeuous One Solution Cell Proliferation Assay kit 
(Madison, WI) according to the manufacturer’s instructions. Cell culture media was exchanged 
24 hours prior to each assessment.  Three cell culture plates were evaluated for each 
experimental group at each time point.  After introducing the colorimetric agent, cell cultures 
were incubated at 37 °C for 2 hours in a humidified 5% CO2 atmosphere. Absorbance at 490 nm 
Figure 2.1: Schematic for hMSC proliferation assay. Experimental groups include: 
Scaffolds; Tβ4-Scaffolds: coated scaffolds with 10μg/mL Tβ4; Tβ4-DMEM: culture 
medium with 1μg/mL Tβ4, and scaffold with both Tβ4 treatments. Three replicates were 
evaluated at each time point.   
Day             
2
Day               
4
Day               
8
Scaffolds in            
TB4-DMEM
TB4-Scaffolds in         
TB4-DMEM
Scaffolds in DMEM 
(Control)




was recorded using a VersaMax 96-well plate reader (VersaMax, Molecular Devices). The 
average absorbance for each experimental group was computed (See Appendix C for protocol).  
In this cell proliferation kit, a tetrazolium compound (MTS) is bioreduced by the cells into a 
color formazan product that is directly proportional to the number viable cells in the culture 
(Promega, 2012).  At day 2, 4 and 8 after cell plating, absorbance was measured to estimate 
relative cell proliferation.  
2.12. Statistical Analysis 
All results are expressed as mean ± SD. A one-way ANOVA and post hoc t-test for 
independent samples were used to evaluate and determine statistical significance for solution 
conductivity and pH measurements due to changes in STMP concentration.  (See Table 2.1).  
HMSC proliferation was evaluated using two-way ANOVA to demonstrate if there were 
statistical differences in proliferation due T4 treatment and time.  Post hoc evaluations were 
conducted using a one-way ANOVA and t-test for independent samples to evaluate statistical 
differences for T4 treatments and time independently and to determine the sources of statistical 
significance for each variable (See Table 2.2).  A value of p < 0.05 (n = 3) was considered 











Analysis Hypotheses Post hoc
one-way 
ANOVA
If Ho rejected, 
perform t-test for 
independent samples 











If Ho rejected, 
perform t-test for 
independent samples 
to identify groups 





Ho: Mean conductivity 
for control and 
PEO/BLG/STMP 
solutions are equal 
Ho: Mean pH for 
PEO/BLG plus NaOH 
and PEO/BLG/STMP 
solutions are equal 
Table 2.2: Two-way ANOVA for hMSC Proliferation Assay 
Hypotheses Post hoc
If Ho rejected, perform one-way 
ANOVA to determine which 
groups are statistical significant, 
followed by t-test for independent 
sample to compare across all 
assessment days 
If Ho rejected, perform one-way 
ANOVA to determine which days 
is statistical significant, followed by 
t-test for independent samples to 
compare across all groups









Ho: Mean hMSC proliferation 
for Tβ4 treatments and control 
are equal
Ho: Mean hMSC proliferation 
for assessment days are equal
Ho: No interactions between 




CHAPTER 3: Effects of Sodium Trimetaphosphate in Poly(ethylene oxide) and β-
Lactoglobulin Electrospinning Solution 
3.1. Introduction 
A study by Sullivan et al. outlined the process to generate electrospun nanofibers using 
aqueous poly(ethylene oxide)-β-lactoglobulin (PEO/BLG) solutions (Sullivan S. T., 2011).  In 
addition to reporting on the PEO/BLG concentrations that yielded defect-free nanofibers, the 
group reported their technique to effectively crosslink PEO/BLG nanofibers by heat treatment. 
This technique rendered nanofibers with structural stability when immersed in aqueous solutions; 
however, Sullivan’s crosslinking technique was time intensive. 
Nanofiber structural stability in aqueous solutions is a fundamental property when using 
scaffolds for tissue engineering (TE) studies.  Typically, TE scaffolds are seeded with cells and 
subjected to cell culturing techniques, which require the use of aqueous based solutions (PBS, 
culturing media, etc.).  The use of materials that produce electrospun nanofibers that are TE 
ready without requiring additional modifications and/or crosslinking treatments is a focus of 
much research (Agarwal, Wendorff, & Greiner, 2009). 
In light of studies reporting crosslinking during nanofiber electrospinning (Shi, Le Visage, & 
Chew, 2011; Jiang, et al., 2015), the focus of this investigation was to evaluate an alternative 
crosslinking method for PEO/BLG electrospun nanofibers.  This approach used sodium 
trimetaphosphate (STMP) as an agent for in situ chemical crosslinking.  STMP at various 
concentrations was added to PEO/BLG solutions. STMP effects on electrospun scaffolds, and its 





3.2.1. Solution Electrospinning 
PEO/BLG and PEO/BLG/STMP solutions were electrospun for 48 hours at ambient 
conditions (22.9±1.4 ˚C and 52.3±4.9 % relative humidity).  For all solutions, the tip-to-collector 
distance was fixed at 15 cm. PEO/BLG solutions were electrospun by extruding the solution at a 
0.1 mL/hr flow rate and applying 7.0 kV (Sullivan, Tang, Kennedy, & Tawlar, 2014).  As 
expected, PEO/BLG/STMP solutions required higher voltages to initiate nanofiber 
electrospinning as a result of adding STMP to PEO/BLG solutions.  The electrospinning voltage 
varied for all STMP concentrations ranging from 15 kV to 22 kV and varied between solution 
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3.2.2. Viscosity Measurements for Electrospinning Solutions  
STMP was added to PEO/BLG electrospinning solution at 2, 4, 6 and 8 w/v % 
concentrations. Viscosity measurements were collected using a rheometer, with a cone geometry, 
by applying constant ramp shear stress.  For the control solutions, PEO/BLG and PEO/BLG plus 
NaOH (PEO/BLG/NaOH) solutions, the viscosity gradually decreased and plateaued along the 
applied shear stress range.  Adding STMP to PEO/BLG electrospinning solutions resulted in S-
shape viscosity profiles for all STMP concentrations (Figure 3.1).  The S-shape viscosity profile 
reveals three distinct behaviors along the applied shear stress:  (1) high viscosity at low shear 
stresses, (2) sudden and/or rapid decrease in viscosity and (3) low viscosity at high shear 
stresses. During low shear stress, viscosity was measured between 100 and 1000 Pa∙s for all 
solutions with STMP.  The results show an increase in viscosity up to two orders in magnitude 
relative to the control group. During high shear stress, viscosities for all STMP concentrations 
plateaued in the same order of magnitude, between 1 to 10 Pa∙s (Figure 3.1).  
 
Table 3.2: Electrospinning Voltages for PEO/BLG/STMP Solutions.   










3.2.3. Conductivity and pH Measurements for PEO/BLG/STMP Solutions 
Solution conductivity was recorded at least 3 times for PEO/BLG (control), PEO/BLG plus 
NaOH and PEO/BLG/STMP solutions.  Average conductivity values for the tested solutions are 
reported in Table 3.3. 
 
 
Figure 3.1: Viscosity vs. Applied shear stress for STMP and Control solutions 
(PEO/BLG/NAOH & PEO/BLG).  STMP solutions displayed a pseudo-plastic behavior, i.e., 
high viscosity at low shear stresses followed by a rapid decrease in viscosity, and plateauing at 
higher shear stresses. The region showing rapid viscosity decrease is less pronounced as STMP 
concentration increased. 2 w/v % STMP solutions demonstrated the least pronounced rapid 
viscosity decrease region. PEO/BLG solutions demonstrated the least variation in viscosity 




PEO/BLG plus NaOH solutions were analyzed first to determine changes in conductivity due 
to NaOH addition since NaOH concentration and volume was constant for all STMP solutions. 
Conductivity significantly increased by 5-fold for 8 w/v % STMP (27.14±0.85 mS/cm), relative 
to control.  Since the concentration and volume of NaOH added to PEO/BLG/STMP solutions 
were the same across all STMP concentrations, PEO/BLG/NaOH solutions were used to 
compare the effects of varying STMP concentrations on solution conductivity (Figure 3.2).  
Adding STMP to PEO/BLG solutions increased solution conductivity which was directly 
proportional to the STMP concentration.  Statistical significance was determined for solutions at 




Table 3.3: Solution Conductivity for PEO/BLG Solutions with NaOH and STMP (Mean 
Solution Conductivity ± Standard Deviation (n = 3). 
Solution
Mean,                        
mS/cm




2 w/v % STMP 11.38 0.10
4 w/v % STMP 17.04 1.24
6 w/v % STMP 22.12 1.06




The pH for PEO/BLG solutions has been previously reported to be 7.5 (Sullivan S. T., 2011). 
Solution pH was recorded at least 3 times for PEO/BLG plus NaOH and PEO/BLG/STMP 
solutions.  Average pH values for each solution are reported in Table 3.4.  pH measurements 
were recorded for all solutions, reaching as high as 12.29 ± 0.08 (2 w/v % STMP).  This result 
was expected since NaOH is a strong base compound.  pH values were lower for all other STMP 
concentrations, i.e. 4, 6 and 8 (p<0.05). The pH of the solutions decreased as STMP 
concentration increased (see Figure 3.3).  However, an unexpected increase in pH was observed 
at 8 w/v % STMP. Furthermore, a post hoc t-test determined statistical significance between 
STMP concentrations of 2, 6 and 8 w/v % (Figure 3.3).  
Figure 3.2: Average solution conductivity for PEO/BLG/STMP solutions (Blue) and 
Control (PEO/BLG) and PEO/BLG/NaOH (Orange).  Differences in conductivity were 
statistically significant among all STMP concentrations and between control groups (*p<0.05, 





Table 3.4: pH for PEO/BLG Solutions with NaOH and STMP. (Mean ± Standard 
Deviation (n =3). 
 
Solution
Mean,                        
pH
S.D.,                         
± pH
PEO/BLG/NaOH 12.31 0.08
2 w/v % STMP 12.29 0.08
4 w/v % STMP 11.89 0.24
6 w/v % STMP 11.68 0.12
8 w/v % STMP 12.01 0.05
Figure 3.3: Average pH for PEO/BLG plus NaOH and PEO/BLG/STMP solutions with 
various STMP concentrations (*p<0.05, One-way ANOVA post hoc t-test). 
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3.2.4. PEO/BLG/STMP Scaffold Characterization 
Scaffold sections were cut and prepared for fluorescent CLSM imaging.  CLSM images were 
acquired from electrospun PEO/BLG and PEO/BLG/STMP dry scaffold sections (Figure 3.4).   
 
Noticeable differences in scaffold topography and nanofiber morphology were observed in 
CSLM images acquired from scaffolds created with PEO/BLG/STMP solutions. 
PEO/BLG/STMP solutions resulted in beaded electrospun nanofibers with solution droplets 
varying in diameter throughout the nanofiber scaffolds.  This pattern was observed across all 
STMP concentrations.  Regarding nanofiber morphology and scaffold topography, solutions with 
2 w/v % STMP resulted in curled and wave-like electrospun nanofibers with minimal 
accumulation and solution droplets with diameters up to 20 μm in diameter. At 4 w/v % STMP, 
linear nanofibers were created with some curved and wave-like nanofibers. The 4 w/v % STMP 
concentrations produced the highest nanofiber accumulation.  Solution droplet diameter 
Figure 3.4: CLSM image of PEO/BLG electrospun fibers. Non-woven linear nanofiber, 
porous scaffold (left). Magnified image illustrating variations in nanofiber diameter (right). 
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decreased to approximately 12 μm, and fewer droplets were observed in the imaging field. With 
6 w/v % STMP, highly beaded linear and curved nanofibers were generated.  Nanofiber 
accumulation decreased relative to 4 w/v % STMP scaffolds and the number of observed 
solution droplets decreased and droplet diameter decreased to approximately 8 μm.  Solutions 
with 8 w/v % STMP resulted in beaded linear and curved electrospun nanofibers.  Observed 
nanofiber accumulation and number of solution droplets were the lowest at this STMP 
concentration. However, the diameter of the solution droplets increased up to approximately 20 
μm at this STMP concentration. 
Although defect-free nanofiber scaffolds from PEO/BLG/STMP solutions were not created, 
scaffold samples were immersed in PBS solution to ascertain if in situ crosslinking was 
accomplished.  Scaffold samples were immersed in PBS for 24 hours and viewed under CLSM.  
The nanofibers dissolved and the scaffolds took on a membrane-like topography (figures not 
shown).  In addition, scaffold samples examined immediately after PBS immersion yielded the 
same scaffold morphology and topography, indicating that the fibers were not crosslinked. 
3.3. Discussion 
Electrospinning defect-free nanofibers from aqueous solutions includes multiple parameters 
including relative humidity and temperature, flow rate, tip-to-collector distance, applied voltage, 
solution composition and viscosity (Doshi & Reneker, 1995).  These parameters dictate the 
outcome of the electrospinning process pertaining to nanofiber morphology and scaffold 
topography.  Thus the synergetic combination of these parameters govern the final outcome in 




Sullivan et al. proposed the feasibility of electrospinning nanofibers from PEO/BLG 
solutions that produced defect-free nanofibers.  Considering that PEO and BLG are both water 
soluble polymers, Sullivan reported that by heat treating PEO/BLG nanofibers over a 5-day 
period the nanofiber cross-linked, rendering their hydrophobic properties.  Following Sullivan’s 
proposed protocols, defect-free PEO/BLG nanofibers were reproduced in the Muller-Borer 
laboratory.  
The purpose of this study was to ascertain the effects of STMP on PEO/BLG solutions and 
the electrospinning process with the long-term goal of developing an alternative cross-linking 
method to heat treatment.  The primary focus of this study was to investigate various STMP 
concentrations and electrospinning parameters that would yield defect-free nanofibers.  STMP is 
a sodium salt that has been reported to effectively cross-link in situ electrospun polysaccharide 
nanofibers (Shi, Le Visage, & Chew, 2011).  
Defect-free nanofibers generated from PEO/BLG were electrospun using 7kV (flow rate of 
0.1 mL/hr). PEO/BLG/STMP solutions required higher electrospinning voltages which differed 
as STMP concentrations increased.  Though electrospinning voltages that lead to nanofiber 
initiation for PEO/BLG/STMP solutions were identified, the resulting nanofibers were not 
defect-free.  Changes in solution composition contributed to changes in nanofiber and scaffold 
morphology, i.e., adding different STMP concentrations to PEO/BLG solutions, and 
modifications to the electrospinning parameters were expected and necessary to initiate 
nanofiber formation.  For all combinations of STMP concentrations and applied voltages, 
nanofibers were beaded and non-uniform in morphology, and solution droplets were deposited 
throughout the electrospun scaffold.  These results are consistent with previous reports 
concerning the effects of solution composition on the electrospinning process (Subbiah, Bhat, 
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Tock, Parameswaran, & Ramkumar, 2005) and for nanofibers electrospun from solutions 
consisting of polymers such as collagen, hyaluronic acid and PEO (Fischer, McCoy, & Grant, 
2012; Sullivan S. T., 2011). Interestingly, at higher STMP concentrations, nanofibers extruded 
outward on the collector’s z-plane making macroscale 3D nanofiber scaffold.  
Given the important role of solution composition on the electrospinning process, solution 
viscosity, conductivity and pH were analyzed.  The rheological assessments of the tested 
solutions revealed that adding STMP to PEO/BLG solutions presented unique effects on solution 
viscosity.  Unlike the viscosity profile for PEO/BLG solutions which decreased, approached a 
limit as shear stress increased and did not exceed 10 Pa∙s, the viscosity profiles for 
PEO/BLG/STMP solutions manifested S-shape curves (Figure 3.1).  S-shape viscosity profiles 
are intrinsic to behavior of Non-Newtonian fluids under shear stress (Barnes, 2000). This further 
emphasizes that the mechanical behavior for electrospinning solutions is dependent on solution 
composition. 
Charges in the polymer solutions are the driving mechanism for nanofiber initiation and 
formation during the electrospinning process.  Therefore, altering solution composition changes 
the charge density in solutions, offering an explanation for the differences observed for solution 
conductivity.  It was shown that adding NaOH and STMP to PEO/BLG solutions increased 
solution conductivity.  Additional increases in STMP concentration increased solution 
conductivity (Figure 3.2).  The increase in solution conductivity can be explain by the fact that 
both NaOH and STMP are ionic salts that when dissolved in water, or aqueous solutions, 
dissociate, freeing ions that increase charge density per volume (Subbiah, Bhat, Tock, 
Parameswaran, & Ramkumar, 2005; Lanigan, 2001).  This further explains the directly 
proportional relationship between solution conductivity and STMP concentration. Changes in pH 
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were expected as NaOH is a strong base and increased to a pH of 12, relative to the control pH 
(7.5) of PEO/BLG blends previously reported by Sullivan et al. STMP concentration also 
affected pH and the results were statistically significant relative to PEO/BLG/NaOH solutions 
for 2 w/v % and 8 w/v % (p<0.05).  pH values recorded for PEO/BLG/STMP solutions varied 
between 11 and 12. Since the pH for PEO/BLG solutions was reported as 7.5 by Sullivan et al., it 
can be concluded that pH is mainly affected by NaOH. Increasing concentrations of STMP 
tended to decrease pH.  However, this decrease in pH was not statistically significant, may be a 
factor of the small sample size and requires further investigation.  
A 2005 study reported the influence of pH on electrospinning poly (vinyl alcohol) (PVA) 
solutions by assessing solution viscosity, surface tension and conductivity as a function of pH (2-
12.9).  The researchers modified pH by using NaOH and showed that conductivity was 
significantly affected by pH, i.e. increasing pH resulted in increased solution conductivity. 
However, it was also demonstrated that solution viscosity and surface tension was not affected 
by changes in pH (Keun Son, Ho Youk, Seung Lee, & Park, 2005).  From evidence provided by 
Keun Son et al.¸ it can be concluded that, in this study, the effects of NaOH on PEO/BLG/STMP 
solutions only contribute to solution conductivity.  The observed changes in nanofiber 
morphology are associated with the effects of STMP concentration on the mechanical properties 
of the solution and solution conductivity. 
Electrospinning solutions are continuously forced through a syringe pump. The solution 
forms a droplet at the tip of the spinneret.  Due to the applied voltage potential between the 
spinneret and the collector, the solution is exposed to an electric field.  The charges in the 
solution move towards the electrode of the opposite polarity which forms a jet and results in 




In order to establish a nanofiber jet, the electrostatic forces must overcome tensile forces in 
the solution droplet at the tip of the spinneret. Solution viscosity and conductivity influence the 
tensile and electrostatic forces during electrospinning, respectively.  During the electrospinning 
of PEO/BLG solutions, once nanofiber formation has initiated, the droplet at the tip of the 
spinneret reduces in size.  However, fiber generation continues uninterrupted due to the constant 
flow through the spinneret.  This pattern was not observed for PEO/BLG/STMP solutions. 
Solutions with STMP produced large droplets that were pulled as a whole from the spinneret. 
Nanofiber jets were initiated, forming nanofibers, but nanofiber formation ceased as a new 
droplet developed at the spinneret.  Nanofibers were not produced continuously despite the 
constant flow rate. 
Figure 3.5: PEO/BLG nanofibers at needle tip during electrospinning process. Figure 
illustrates solution droplet, jet formation and initiation nanofiber. 
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The continuous and uninterrupted formation of nanofibers is the result of the electrostatic 
forces that overcome the surface tension of the droplet at the spinneret (Doshi & Reneker, 1995). 
It was previously mentioned that the main effect of adding salts (NaOH and STMP) results in an 
increase in solution conductivity.  Although solution conductivity significantly increased with 
STMP concentration (Table 3.3), the changes in solution composition by the addition of STMP 
to PEO/BLG solutions is the main factor contributing to nanofiber morphology.  Beaded 
nanofibers were created, nanofiber accumulation deceased and scaffold porosity increased with 
increased STMP concentration.  These changes coincide with various studies that report on 
electrospinning polymer blends with different weight ratios and the effects on nanofiber 
morphology (Aluigi, et al., 2008; Colín-Orozco, Zapata-Torres, Rodríguez-Gattorno, & Pedroza-
Islas, 2015; Fischer, McCoy, & Grant, 2012; Sullivan, Tang, Kennedy, & Tawlar, 2014).  
PEO/BLG/STMP solution viscosity increased considerably relative to the PEO/BLG 
solution.  The S-shape viscosity profiles recorded for PEO/BLG/STMP solutions (Figure 3.1) has 
been described for other Non-Newtonian fluids which experienced a rapid decrease in viscosity 
at a very small shear stress.  This region of rapid decrease in viscosity has been identified as 
shear-thinning, which to the behavior of nanofiber formation for PEO/BLG/STMP solutions 
(Barnes, 2000).  Large electrostatic forces were necessary to overcome the high viscosities 
imposed by low shear stresses, as the droplet at the spinneret increased in size, charge density 
increased.  Upon reaching sufficient magnitude, the solutions experienced shear-thinning, and 
decreased viscosity, allowing for the electrostatic forces to overcome tensile forces.  Verifying 
this requires further research to assess charge density and current measurements for STMP 
solutions for the electrospinning conditions reported in this study 
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Despite being unsuccessful in producing defect-free nanofibers, scaffold samples were 
immersed in PBS solution to determine if in situ crosslinking due to STMP and NaOH had 
occurred.  BLG has two intrachain disulphide bridges and a free thiol group within its primary 
structure in the form of cysteine amino acids, which due to their high reactivity can served as 
potential crosslinking sites (Hernández-ledesma, Recio, & Amigo, 2008).  Crosslinking was not 
accomplished since upon immersion in PBS the nanofibers dissolved (images not shown).  The 
disulphide bridges and free thiol group are encapsulated within the internal structure of BLG.  It 
was anticipated that an increase in pH due to NaOH would denature and unfold BLG, exposing 
cysteine reactive groups to influence crosslinking.  Base-induced denaturation for BLG has been 
reported.  These studies report that BLG unfolding occurs in a transitional manner from pH 9-13 
and pH 5-12 where small portions of the secondary structures are preserved (Taulier & 
Chalikian, 2001) and complete unfolding occurs at high pH (Partanen, et al., 2011).  Due to the 
different results reported on BLG unfolding and denaturation at basic pH it is unclear why there 
was no evidence of nanofiber crosslinking.  According to Taulier et al.¸ if small secondary 
structures are preserved, it can be argued that these structures may contain the disulphide 
bridges.  Therefore, a reducing agent may be necessary to reduce the disulphide bonds and 
making the thiol group available for crosslinking; however, this does not explain why 
crosslinking did not occur on the free thiol group. 
3.4. Conclusion 
This work represents efforts to develop an alternative crosslinking technique to prolonged 
heat treatment for PEO/BLG nanofibers.  In this study, PEO/BLG solutions were prepared with 
various STMP concentrations.  PEO/BLG/STMP nanofibers were electrospun to assess 
electrospinning parameters that may yield defect-free nanofibers.  Specific parameters were 
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identified to generate electrospun nanofiber scaffolds.  However, CLSM imaging revealed that 
defect-free nanofibers were unattainable under the tested electrospinning parameters.  Viscosity, 
conductivity and pH were assessed for PEO/BLG/STMP solutions to determine the effects of 
adding STMP and NaOH to PEO/BLG solutions. STMP in combination to NaOH has been 
shown to chemically crosslink polysaccharide nanofiber during the electrospinning process.  
Ultimately, adding STMP did not chemically crosslink PEO/BLG and defect-free nanofibers 
were not obtained.  This approach was determined to not be suitable or efficient for producing 
biological scaffolds for TE.  Additional research in polymerchemistry is suggested to advance 





CHAPTER 4: Assessment Stem Cell Proliferation Using Poly(ethylene oxide) and β-
Lactoglobulin Electrospun Nanofibers 
4.1. Introduction 
Numerous methods have been reported for the fabrications of scaffolds for tissue engineering 
(TE) (Vasita & Katti, 2006).  There are multiple reasons supporting the use of electrospun 
nanofibers for TE.  The versatility of modification for numerous applications, cost-effective set-
up and process has made the electrospinning process a common tool for research.  This has 
allowed the fabrication of tissue specific nanofiber scaffolds with abilities to control scaffold 
thickness, porosity and nanofiber diameter.  In addition, the technique has allowed for the 
fabrication of nanofiber scaffolds composed of biodegradable and natural polymers, improving 
the biocompatibility properties of nanofibers scaffolds.  In addition, the nanoscale nature of 
electrospun nanofibers provides characteristics intrinsic to the extracellular matrix, promoting 
cellular function and interaction (Kriegel, Arrechi, Kit, McClements, & Weiss, 2008; Jiang, et 
al., 2012; Jiang, et al., 2015).  Consequently, the use of electrospun nanofibers for TE and 
regenerative medicine applications has resulted in increased research interest.   
Poly(ethylene oxide) (PEO) is a water soluble thermoplastic polymer that, due to its 
biocompatibility and low toxicity, has been extensively studied for biomedical and food 
applications (Colín-Orozco, Zapata-Torres, Rodríguez-Gattorno, & Pedroza-Islas, 2015).  For 
PEO and biopolymer solutions, PEO is used as a visco-modifier to enhance electrospinnability of 
biopolymers and proteins for generating electrospun nanofibers.  The combination of PEO and β-
lactoglobulin (BLG), a globular protein found in whey, for electrospinning solutions has 
previously been reported (Sullivan, Tang, Kennedy, & Tawlar, 2014).  Due to their composition 
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consisting of biocompatible and natural polymers, Sullivan et al. suggested that PEO/BLG 
electrospun nanofibers may have potential applications as TE constructs. 
The purpose of this study was to evaluate, for the first time, PEO/BLG electrospun 
nanofibers as TE constructs for human mesenchymal stem cells (hMSCs).  HMSCs were seeded 
onto PEO/BLG scaffolds.  HMSC proliferation was evaluated on naïve PEO/BLG scaffolds and 
on PEO/BLG scaffolds functionalized with the wound healing protein were thymosin-β4 (Tβ4).  
Among the previously mentioned qualities that have promoted research interest for electrospun 
nanofibers in TE, recent research has demonstrated the capabilities of functionalizing nanofibers 
with a variety of biological factors that when used for TE can promote various cellular functions. 
Among these biological factors, Tβ4 has been shown to promote wound healing, angiogenesis, 
migration, proliferation, growth, and suppression of tissue inflammatory response (Ti, et al., 
2015). Furthermore, a recent study showed that Tβ4 functionalized poly(ε-caprolactone) 
electrospun nanofibers promoted the growth and differentiation of murine derived 
cardiomyocytes (Kumar, Patel , Duvalsaint, Desai, & Marks, 2014 ).  Additionally, the desire to 
investigate Tβ4 as a biological functionalizing agent advances previous research conducted in the 
Muller-Borer laboratory (Byrum, 2008; Crifasi, 2011).  In this study a total of four experimental 
groups were analyzed to ascertain the effects of PEO/BLG electrospun nanofibers and Tβ4 









4.2.1. HMSC proliferation 
A colorimetric assay to evaluate hMSC proliferation was performed 2, 4 and 8 days after 
hMSC plating.  HMSCs remained viable throughout the cell culturing period, and hMSC 
proliferation increased with time for the Tβ4 experimental groups (see Figure 4.1).  
A two-way ANOVA showed statistical significance for hMSC proliferation due to Tβ4 
treatment and assessment days as well as interactions between both independent variables.  To 
identify the sources of statistical significance for each independent variable, post hoc analyses 
were conducted to compare proliferation of the experimental groups with respect to each 
assessment day (Table 4.2) and proliferation at all assessment days with respect to individual 





Table 4.1: Experimental Groups for hMSC Proliferation Assay. 
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One-way ANOVA comparing proliferation of the experimental groups for each assessment 
day showed statistical significant differences only for Day 4 and 8 (Figure 4.2).  Furthermore, t-
test pairwise comparison demonstrated statistically significant differences in hMSC proliferation 
among all the experimental groups at Day 4 and 8 (Figure 4.3).  Interestingly, the Control group 
exhibited the highest hMSC proliferation at Day 4.  
  
Figure 4.1: HMSC proliferation increased with time in culture. HMSC proliferation 
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Figure 4.2: hMSC proliferation at days 2, 4 and 8 (*p<0.05, One-way ANOVA, n=3 per 




One-way ANOVA comparing hMSC proliferation at day 2, 4 and 8 for each experimental 
group revealed statistically significant differences for all experimental groups.  T-test for 
independent samples demonstrated statistically significant differences in cell proliferation for 
individual experimental groups at each time point except for Group 2.  HMSC proliferation 
increased from Day 2 to Day 4 and decreased from Day 4 to Day 8 for Group 1 (Control).  
HMSC proliferation increased from Day 2 to Day 8 for Group 2, and hMSC proliferation 




Figure 4.3: hMSC proliferation comparisons at Day 4 and Day 8 (*p<0.05, t-test for 
independent samples, n=3 per group). HMSC proliferation was statistically different between 




4.3. Discussion  
When culturing hMSCs in vitro, cell proliferation is dependent on cell seeding density, the 
available surface area in the culturing vehicle, and time.  When using standard cell culture 
dishes, seeded cells adhere to the bottom of the dishes and migrate to nearby cells to form small 
aggregates.  Cell-to-cell signaling promotes proliferation allowing cells to divide and multiply. 
Proliferation continues until hMSCs become confluent, forming a 2D layer in the cell culture 
dish. Furthermore, hMSC cultures can be treated with factors to induce differentiation. By 
inducing differentiation, the hMSCs become tissue specific and can be used for tissue 
engineering (TE) applications. 
When culturing hMSCs on constructs, such as electrospun nanofiber scaffolds, scaffolds 
increase the cell culture surface area by providing a 3D architecture for seeded hMSCs to adhere, 
Figure 4.4: hMSC proliferation comparisons per experimental groups (*p<0.05, one-way 
ANOVA and t-test for independent samples, n=3 per group). 
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migrate, integrate, proliferate and differentiate.  In addition, the nanofiber nature of electrospun 
scaffolds mimic the native extracellular matrix (ECM), which further promotes cellular function 
(Lodono & Badylak, 2015).  These aspects have driven research efforts in using 3D constructs 
for developing complex, differentiated tissue in vitro from hMSCs for TE applications that may 
result in new innovative clinical applications.  
PEO is a biodegradable and biocompatible polymer. BLG is a natural small globular protein 
found in bovine milk consisting of 162 amino acid residues (Chatterton, Smithers, Roupas, & 
Brodkorb, 2006).  Electrospinning PEO and BLG create nanofibers with biochemical properties 
from both of materials.  Heat treatment of PEO/BLG nanofibers partially denatures BLG by 
exceeding its gelation temperature, exposing the hydrophilic portions of the molecule when 
immersed in aqueous solutions (Oakenfull, 1996).  Thus, the final outcome of these two 
processes are crosslinked, aqueously stable PEO/BLG nanofiber scaffolds that can be used for 
multiple engineering applications (Sullivan, Tang, Kennedy, & Tawlar, 2014).  These 
characteristics provide a basis for evaluating PEO/BLG electrospun nanofibers for hMSC 
constructs to determine their feasibility for TE applications.  
The focus of this study was to determine the effects on hMSC proliferation in the presence of 
PEO/BLG nanofiber scaffolds (Group 1, Control), and when scaffolds were treated with Tβ4 
(Group2, Tβ4scaff/DMEM), when Tβ4 was added to the cell culture medium (Group3, 
Scaff/Tβ4DMEM), and the combination of Tβ4 treated scaffolds and cell culture media (Group4, 
Tβ4 Both). 
Proliferation was expected to increase significantly for the Tβ4 experimental groups, relative 
to the control, since Tβ4 promotes cell migration and proliferation (Ti, et al., 2015).  HMSC 
proliferation was statistically significant for each experimental condition at Day 4 and 8 
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(p<0.05).  The Tβ4 experimental groups did not provide conditions to significantly enhance 
hMSC proliferation in early culture (Day 2), but instead provided similar culturing conditions as 
the control group.  
Proliferation increased at day 4 after cell plating. HMSC proliferation for individual groups 
significantly increased from day 2 to 4 except for Group 2.  Control demonstrated the greatest 
increase in hMSC proliferation at day 4. HMSC proliferation results for the control group were 
unexpected.  Given that the control group consisted of PEO/BLG scaffolds and hMSCs only, at 
least one of the Tβ4 groups should have exceeded the proliferation result for the control.  A two-
way ANOVA revealed that there were significant interactions between the independent 
variables.  These interactions can be seen in the hMSC proliferation profiles for the Groups and 
control (Figure 4.1).  Proliferation increased with time for Groups 2, 3 and 4, but the control did 
not exhibit this pattern. 
At day 8, hMSC proliferation was statistically significant among the experimental groups. 
HMSC proliferation was greatest for Group 3 and lowest for the control.  This suggests that Tβ4 
treatment has a positive effect on hMSC proliferation, relative to the control group.  Comparing 
proliferation for day 4 to day 8, hMSC proliferation increased for all experimental groups except 
the control. 
Tβ4 treatment affected proliferation within experimental groups only. HMSC proliferation 
increased for Group 3 and Group 4 groups at each time point.  HMSC proliferation only 
increased for Group 2 between day 4 and 6.  The variations between Tβ4 groups at a different 
times did not show a consistent pattern. Therefore, a Tβ4 treatment that yielded the most 
significant increase in proliferation with respect to time was not identified.  This may be due to 
the interaction between the independent variables and the difference in Tβ4 concentrations used 
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for Group 2, 3 and 4, which were 1 μg/mL or 10 μg/mL. However, hMSC proliferation for 
Group 4 was expected to be highest at all assessment days and among experimental groups since 
it combined the treatments for Group 2 and 3.  Therefore, further research is necessary to 
determine an efficient Tβ4 concentration and/or treatment that will promote hMSC proliferation 
in PEO/BLG nanofiber scaffolds.  In addition, it is also necessary to develop methods to evaluate 
Tβ4 interaction with PEO/BLG nanofiber scaffolds. 
Despite seeding hMSCs on top of the PEO/BLG scaffolds, hMSCs migrated and adhered to 
the bottom of the cell culture dish for all experimental groups suggesting that the hMSCs did not 
integrate with the scaffolds.  Thus, this investigation only showed that PEO/BLG nanofiber 
scaffolds do not affect hMSC viability and Tβ4 can increase hMSC proliferation given these 
culturing conditions. 
There are multiple limitations that may have influenced the outcome of this study.  Cell 
culture replicates are independent samples and their proliferation can be affected by many factors 
such as variation in cell seeding density, scaffold thickness and culture medium volume.  In 
addition, variations on replicates also arise from the nature of samples being independent and 
using a small number sample size may not represent the true behavior of hMSC.  This 
contributes to the standard deviation for the mean value for proliferation for each experimental 
group.  
 The scaffolds were observed to take on a concave structure in the culture dish when medium 
was added.  The scaffold’s edge adhered to the culture well’s wall at the top of the culture 
medium volume with scaffold centers reaching the bottom of the well.  Variations in scaffold 
size can limit the available area in the culture well for cells to adhere and proliferate.  Also, 
tissue-grade culture dishes were used for this study which indicates the resulting low of 
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integrations of hMSC to PEO/BLG nanofiber scaffolds.  Tissue-grade culture dishes are 
functionalized with negative charges on culturing surface.  Compared to the distributions of 
amount of negatively charged amino acids within the primary structure of BLG, negative charges 
on the culturing surface are free to electrostatically interact with positively charged cell-wall 
binding proteins in hMSC.  In addition to hydrogen-bond interactions among the primary 
structure of proteins, polar and charged amino acids play a major role in defining the secondary 
structure and tertiary structure of proteins.  Therefore, this further decreases the availability of 
free amino acid charges in BLG/PEO electrospun nanofibers to interact with hMSC binding 
proteins.  To improve this study, non-tissue grade culture dishes, smaller scaffolds and less 
culture medium should be considered to improve hMSC interactions with PEO/BLG scaffolds. 
4.4. Conclusion 
The effects on cell viability and proliferation due to seeding and culturing hMSCs onto 
PEO/BLG nanofiber scaffolds and PEO/BLG nanofiber scaffolds treated with Tβ4 were 
demonstrated.  HMSC cultures were prepared and kept for 8 days. HMSCs did not integrate into 
the nanofiber scaffolds; however, PEO/BLG scaffolds did not have a negative effect on hMSC 
viability.  HMSC proliferation increased for the Tβ4 treated groups at different levels. This study 
reports on using PEO/BLG nanofibers as TE constructs for the first time, and demonstrates that 
hMSC cell proliferation increased throughout the culture period demonstrating their potential for 
future research in TE.  Challenges ahead and research directions for using PEO/BLG scaffolds 
for TE may include: determining how to integrate cells into the scaffold, determining an 
effective Tβ4 concertation that will promote cell proliferation, determining an alternative 
crosslinking mechanism to expedite scaffold readiness for TE purposes and modifying the 
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APPENDIX A – Electrospinning Solution Preparation Protocol 
1. Introduction  
Electrospinning is a process in which liquid solutions are used to produce solid structures by 
exposing the solutions to an electric field.  Depending on the electrospinning device set-up and 
type of electrospinning solution, thin fibers can be produced within the micro- and nano-scale.  
Set-up simplicity and relative ease-of-use has made electrospinning a favorite among the 
modalities for producing thin fibers. This has allowed the development of numerous applications 
throughout different engineering disciplines including scaffolds for tissue engineering (TE) 
applications.  
A previous study by Sullivan et al. reported the on the formulation and parameters to produce 
electrospun nanofibers from solutions containing poly(ethylene Oxide) (PEO) and β-
lactoglobulin (BLG).  Sullivan’s formulation was modified by adding sodium trimetaphosphate 
(STMP) and sodium hydroxide (NaOH) to investigate their potential as an in situ chemical 
crosslinker.  The formulation for making PEO/BLG/STMP solutions including STMP at 2, 4, 6 
and 8% (w/v) into Sullivian’s formulation for PEO/BLG electrospinning solution are described 
in the following sections 
2. PEO/BLG/STMP Electrospinning Solution preparation 
 Materials 
 Ultra-pure deionized water 
 Poly(ethylene oxide) powder 
 β-lactoglobulin powder 
 Sodium trimetaphosphate powder 
 0.02 % Rhodamine-B 
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 10 w/v % Sodium hydroxide 
 Sterile 50 mL glass containers with lid (2x) 
 Stir plates (2x) 
 Sterile stir bars (2x) 
 Protocol 
Aliquot 20 mL of ultra-pure deionized water into two 50 mL containers and place stir bar 
into the container.  Place containers on stir plates and turn on the stir plates to approximately 120 
rpm. Measure 8 w/v % PEO and 12 w/v % BLG powder using an electronic scale, approximately 
1.6 g and 2.4 g, respectively.  Slowly add PEO powder into one container and BLG into the 
second container.  Secure tops and allow the powders to dissolve for approximately one hour or 
until the BLG powder has completely dissolved.  Combine both solutions by pouring the BLG 
solution into the PEO solution, note that the PEO powder may not be fully dissolved or may be 
have formed droplets.  Add 10 w/v % NaOH at a 1:10 volume-to-volume ratio 
(NaOH:PEO/BLG solution), stir solution overnight (approximately 12 hours).  On the following 
morning, add the desired amount of STMP (2-8 w/v %).  Rhodamine-B (RHB) is a dye which 
was used to stain the nanofibers and facilitate imaging with confocal laser scanning microscopy.  
Calculate the desired RHB concentration and add the corresponding RHB volume to the 
electrospinning solutions.  For these experiments, RHB was added to obtain a concentration in 
the range of 0.0001-0.0005 v/v % RHB. RHB is photo-sensitive, cover the container with 
aluminum foil and stir the solution until the STMP has completely dissolve (approx. 2 hours).  
The solution is ready for electrospinning.
 
 
APPENDIX B – PEO/BLG Scaffold Preparation for hMSC Cultures and Thymosin-β4 
Coating Protocol 
1. Introduction 
Nanofibers were electrospun from aqueous poly(ethylene oxide) (PEO) and β-Lactoglobulin 
(BLG) solutions.  PEO/BLG solutions consisting of 8 w/v % PEO, 12 w/v % BLG (1:1 mixture) 
and 0.0001 v/v % Rhodamine-B. PEO/BLG electrospun nanofibers were evaluated as a stem cell 
construct for potential tissue engineering applications.  Step-by-step instructions are provided for 
preparing electrospun nanofibers into cell-culture ready scaffolds.  This section describes the 
following methods: 
 Nanofiber preparation for crosslinking 
 Crosslinking process 
 Scaffold sterilization  
 Scaffold hydration and thymosin-β4 (Tβ4) coating 
2. Nanofiber Preparation for Crosslinking 
 Materials 
 Scissors 
 Electrospun nanofibers on collector 
 14 mm diameter circular punch (corresponding area of a 24-well plate) 
 Scalpel (No. 10 blade) 
 High precision needle tip and flat tip tweezers 
 Heat-resistant containers with lids  
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Nanofibers accumulate onto an aluminum collector, which covers the collector base, during 
electrospinning.  Once the electrospinning is completed, carefully removed the aluminum 
collector from the collector base.  Trim the aluminum collector and dispose of the areas where 
there was no nanofiber accumulation.  Gently place the collector into its corresponding sample 
bag, be sure to do this with extreme caution so the nanofibers are not damaged.  You may either 
store the aluminum collector in a dark place for future experiments or proceed to prepare the 
nanofibers for crosslinking.  
 Nanofiber Scaffold Preparation  
 Remove the aluminum collector from the sample bag and place on the bench top 
 Starting on an edge, outline 14 mm circle by gently pressing the punch onto the 
Figure B.1: Outlining PEO/BLG nanofiber scaffolds with punch 
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aluminum collector (Figure B.1).  
 Cut along the punch’s circumference using a scalpel to produce a circular scaffold 
sample 
 Lift the punch up and collect the scaffold sample using tweezers. If the scaffold 
sample gets trapped inside the punch, use needle tip tweezers to tilt the scaffold 
sample onto its edge, then retrieve the scaffold sample from within the punch.  
 Gently load scaffold sample into the heat-resistant containers. Do not stack scaffold 
samples. Scaffold samples are extremely light weight and tend to drift with air 
currents produced by body movement.  Stainless steel surgical containers with lids 
(Figure B.2) are recommended to prevent the scaffolds samples from drifting in the 
air. Surgical containers can be used for crosslinking.  
Figure B.2: Scaffold arrangement for crosslinking 
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 Work towards the center of the aluminum collector as you continue cutting scaffold 
samples.  Repeat process until the desired number of scaffold samples have been cut. 
 If any uncut nanofibers left, place the aluminum collector back into the sample bag 
and store in a dark place for future experiments. 
3. Scaffold Crosslinking and Sterilization 
Materials 
 Scaffold samples (14 mm diameter) in heat-resistant trays 
 Gravity convection oven 
 Multi-well plates (24-well) 
 Sterile high precision needle tip tweezers 
 Biological hood equipped with UV-light 
Turn the oven on and set the temperature to 100°C on LOW.  Allow for the temperature 
to stabilize.  Place the cut scaffold samples in heat-resistant trays.  Crosslink the scaffold 
samples for 96 hours.  After crosslinking, turn the oven off and let it cool down to room 
temperature.  Remove trays containing the crosslinked scaffold samples from the oven. 
 Post-Crosslinking Sterilization 
From this point on all work should be done in a biological hood using standard sterile 
techniques 
 Turn the biological hood ON. Allow the blower to run for 5-10 minutes 
 Place multi-well plates and tweezers in the biological hood 
 Remove scaffold tray(s) from the oven and place it in the biological hood 
 Remove the multi-well plate from its packing 
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 Remove the lid from the multi-well plate 
 Load scaffolds into wells, one scaffold per well, make sure that the scaffold lays flat 
on the well’s bottom 
 Once the multi-well plates are loaded, remove any tools and plastic containers from 
the biological hood 
 Turn the UV-Light ON and expose for at least 12 hours 
 After the first 12 hours, carefully turn the multi-well plate(s) upside down, turn the 
UV-light ON and expose for at least 12 hours. 
4. Scaffold Hydrations and Thymosin-β4 coating 
Materials 
 1x Phosphate buffer saline (PBS) 
 Thymosin-β4 (Tβ4)  
 1000 µL pipet and pipet tips 
 Multi-well plates with UV-sterilized scaffolds 
 Protocol 
Hydrate scaffolds by pipetting 300 µL of PBS onto the scaffold, repeat for each well, then 
add an additional 200 µL of PBS to each well; each well should contain 500 μL PBS.  Use a new 
pipet tip for each well.  When hydrating the scaffolds, pipet PBS into the well by touching the 
pipet’s tip onto the well’s wall.  Note that the scaffold may rotate as the PBS is pipetted into the 
well due to momentum.  Place scaffolds into a 5% CO2 atmosphere incubator and allow scaffolds 
to hydrate for 24 hours.  After hydration, remove 350 μL PBS from the wells (3- 100 µL and 1- 
50 μL aspirations).  Avoid aspirating the scaffold into the pipet tip by pushing the scaffold edge 
towards the well’s center or by placing the pipet tip under the scaffold.  Once the PBS has been 
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removed use the pipet tip to adjust the scaffold so it covers the entire well.  At this point the 
scaffolds are hydrated and cell-culture ready. 
For Tβ4 coated scaffolds, Tβ4 is added to PBS and used for hydration and coating. Prepare 
the Tβ4 coating solution by dissolving (or diluting) Tβ4 stock solution in PBS to a concentration 
of 10 μg/mL Tβ4-PBS.  Pipet 200 μL of 10 μg/mL Tβ4-PBS into each well as described above. 
Place scaffolds into a 5% CO2 atmosphere incubator and allow scaffolds to hydrate for 24 hours. 
After Tβ4-coating hydration, add 300 μL PBS to wash any unbound Tβ4 and incubate for 1 hour.  
Remove 350 μL Tβ4-PBS/PBS as described above 
 Justification for 200 μL Hydration volume & removing 350 μL PBS after Hydration 
From previous preliminary experiments, we determined that 200 μL of hydration solution is 
the minimum volume that will not cause the scaffold to curl into itself when hydrating or coating 
with Tβ4.  Furthermore, after hydrating, we sought to determine the maximum amount of 
hydration solution that when aspirated from the well no air (bubbles) was aspirated, subsequently 
determining the amount of hydration solutions absorbed by the scaffold.  Using 500 μL of 
hydration solution, we determined that, on the average, scaffolds absorb 150 μL of hydration 








APPENDIX C – hMSC Seeding, Cultures and Proliferation 
1. Introduction 
Human mesenchymal stem cells (hMSCs) viability on electrospun nanofiber scaffolds was 
assessed.  Step-by-step instructions for seeding and culturing hMSCs on electrospun scaffold and 
conducting proliferation assays is provided. In this experiment, hMSCs were cultured for 8 days. 
Proliferation was assessed at Day 2, 4 and 8.  
2. Cell Seeding and Cultures 
 Materials 
 Frozen Adult hMSCs with green fluorescent protein  
  Complete media – Dulbecco’s Modified Eagle Medium (DMEM) with 16.5 % Fetal 
bovine serum (FBS) and 1% Penicillin-streptomycin (Pen-Strep) 
 Thymosin-β4 (Tβ4) 
 Cell counting Trypan-Blue 
 Ice caddy  
 Protocol 
 Calculate the volume of complete media needed. Account for volumes for diluting 
freezing media after thawing (hMSCs are frozen and preserved in a freezing media 
solution containing 10% DMSO, which must be diluted to < 1% DMSO after 
thawing), seeding and filling after seeding. 
 Calculate the amounts of FBS and Pen-step needed 
 Prepare complete media by mixing FBS and Pen-Strep into DMEM 
 Aliquot complete media for filling and for mixing with Tβ4 
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 Carefully remove hMSCs from the liquid nitrogen Dewar and thaw cells using 
standard techniques. Information regarding cells, their location and contents of the 
freezing media documented in the liquid nitrogen log book. 
 Add thawed cells into a 15 mL conical tube with enough complete media that will 
dilute the DMSO to < 1%. Note that DMSO is highly toxic to the cells, so this step 
should be promptly performed once cells are fully thawed.  
 Place the conical tube in the centrifuge and spin cells for 5 minutes at 1500 rpm. This 
will pelletize the cells from the supernatant.  
 Dispose of the supernatant by inverting the conical tube allowing the supernatant to 
drain into a collection container. The cell pellet should remain at the bottom of the 
tube. 
 Add enough media so it approximates the desire cell concentration (cells/mL). Mix 
media with pipet (or vortex) so the cells become suspended 
 Remove 25 μL of cell suspension and mix with Trypan-Blue at 1:1 volume ratio. 
 Count cells to determine mortality ratio and live cell concentration 
The cells are ready for seeding. Depending on the number of wells and cells needed, you 
may need to further dilute the cell suspension or if cell concentration is too low, you may 
need to pelletize the cells again to adjust for the correct cell concentration.  
 Pipet 50 μL of cell suspension into each well 
 Place culture dishes into incubator for 30 minutes to allow cells to adhere to scaffolds 
There are four experimental groups: (1) scaffolds in complete media (control), (2) Tβ4-
scaffolds in complete media, (3) scaffolds in Tβ4-complete media and (4) Tβ4-scaffolds in 
Tβ4-complete media.  Scaffolds absorb 150 μL of hydration solution, cells are seeded using 
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50 μL of cell suspension and the final well volume is 500 μL. Therefore, groups 1 and 2 
require an additional 300 μL. For groups 3 and 4, prepare Tβ4-complete media by diluting 
Tβ4 stock solution to a concentration of 1 μg/mL in complete media, then pipet 300 μL of 
Tβ4-complete media into each of well for groups 3 and 4. Place culture plates into 5% CO2 
atmosphere incubator. 
3. Viability and Proliferation – PROMEGA KIT 
HMSCs were cultured on Tβ4 treated- and non-treated electrospun scaffold for 8 days. 
HMSC proliferation was assessed on days 2, 5 and 8.  The following protocol was used for each 
time point. 
 Materials 
 Complete media – Dulbecco’s Modified Eagle Medium (DMEM) with 16.5 % Fetal 
bovine serum (FBS) and 1% Penicillin-streptomycin (Pen-Strep) 
 Thymosin-β4 (Tβ4) 
 PROMEGA proliferation reagent 
 Protocol 
The day before conducting the proliferation assay, exchange the media for the wells that will 
be analyzed.  Therefore, calculate and prepare complete media and Tβ4-complete media. On the 
following day, remove 200 μL of media leaving the cell cultures in 300 μL media.  The 
PROMEGA kit calls for 20 μL of proliferation reagent per 100 μL of cell culture media; 
therefore, each well will require 60 μL of proliferation reagent.  PROMEGA’s proliferation 
reagent is photo-sensitive, working with minimal light add 60 μL of proliferation reagent into 
each well.  Place culture dishes into the incubator and incubate for 2 hours.  The cell cultures will 
turn black or purple, this is indicative of the colorimetric reaction that the proliferation reagent 
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induces on the cell cultures for assessing proliferation.  Remove culture dishes from incubator. 
Remove 200 μL from each well and pipet into a 96-well plate. Assess proliferation using a 96-
well plate reader.  
 
 
 
